Aiming to Commercially Produce Active Pharmaceutical Ingredients
We entered into an ECC with Genopaver, LLC, to collaborate on developing and commercializing products in the field of the fermentative production of alkaloids.  The ECC aims to utilize genetically modified cell-lines and substrate feeds to produce alkaloids for use as active pharmaceutical ingredients or as commercially sold intermediates in the manufacture of active pharmaceutical ingredients. 
The first program under this ECC involves the microbial production of an active pharmaceutical ingredient used primarily in the development of several commonly used pain killers. The purpose of our ECC with Genopaver is to develop a source of this valuable component at a commercially competitive cost.
In the News